Concepedia

Mark Heise

MH

18

Publications

4.8K

Citations

17

H-Index

2000

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

Harvard University

CSL (United States)

University of Toronto

University of Washington

Mark Heise is an author at GlaxoSmithKline (United States) specializing in pharmacology, medicine, and diabetes.

ORCID

Top concepts

Publications per year

2000–2024

18

Publications

18

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

Steven E. Kahn, Steven M. Haffner, Mark Heise et al. · New England Journal of Medicine · 2006 · 2.9K citations

Rosiglitazone-Associated Fractures in Type 2 Diabetes

Steven E. Kahn, Bernard Zinman, John M. Lachin et al. · Diabetes Care · 2008 · 537 citations · Full text

A Diabetes Outcome Progression Trial (ADOPT)

Giancarlo Viberti, Steven E. Kahn, Douglas A. Greene et al. · Diabetes Care · 2002 · 269 citations · Full text

Rosiglitazone reduces urinary albumin excretion in type II diabetes

George L. Bakris, Giancarlo Viberti, Wayde M. Weston et al. · Journal of Human Hypertension · 2003 · 240 citations

, , +7

Phenotypic Characteristics of GAD Antibody-Positive Recently Diagnosed Patients With Type 2 Diabetes in North America and Europe

Bernard Zinman, Steven E. Kahn, Steven M. Haffner et al. · Diabetes · 2004 · 193 citations · Full text

Rows per page

1–5 of 18